Impact of premature rupture of membranes and preterm premature rupture of membrane on maternal and neonatal outcomes
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254289Keywords:
PROM, PPROM, Maternal outcomes, Neonatal outcomes, Latent periodAbstract
Background: Premature rupture of membrane (PROM) and preterm premature rupture of membrane (PPROM) has significant adverse events in the prenatal, peripartum, and neonatal period. The objective of the present study is to understand the risk factors of PROM and PPROM and delivery outcomes in these subjects along with subgroup analysis on comparison of latent period less than 24 hours (group-1) and more than 24 hours (group-2).
Methods: The present data was retrospectively analysed in a private multispeciality birthing centre at Chennai which included a total of 61 cases of PROM and PPROM over a period of six months (January 2022–June 2022).
Results: Among 54% (n=33) of the study participants (n=61) were ranging from 30–35 years. Among n=49 PROM cases and n=12 PPROM, n=25 (51%) (including 8 vacuum assisted) and n=6 (50%) mothers had normal vaginal delivery respectively. Also, among study participants, n=13 (21%) subjects were in latent period more than 24 hours and n=49 (80%) subjects were in latent period of less than 24 hours. The maternal complications in both subgroups showed n=1 case of atonic postpartum hemorrhage (PPH) and puerperal pyrexia. Among the neonates, there were 2 incidences of hypoglycemia in both subgroups of LP. Two cases of sepsis in LP <24 hours and in LP >24 hours respectively. Among the 4 neonates with respiratory distress, 3 neonates were shifted to higher centre and were effectively managed.
Conclusion: Early diagnosis and prompt management of PROM and PPROM can reduce the risk of maternal and neonatal mortality.
References
Endale T, Fentahun N, Gemada D, Hussen MA. Maternal and fetal outcomes in term premature rupture of membrane. World J Emerg Med. 2016;7(2):147-52.
American College of Obstetricians and Gynecologists. Prelabor rupture of membranes: ACOG practice bulletin, number 217. Obstet Gynecol. 2020;135(3):e80-97.
Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scandinavica. 2008;87(6):590-600.
Rajani P, Mounika D. A Prospective Study of Maternal and Perinatal Outcome in Pre-Labor Rupture of Membranes at Term Gestation. Eu J Mol Clin Med. 2021;8(4):2685-92.
Mondal SK, Kanoongo S. A study on management of premature rupture of membranes. Int J Reprod Contracept Obstet Gynecol. 2018;7(3):855-9.
Lawan ZM, Bako B, Idrisa A, Bukar M, Gadzama GB. Risk factors of prelabor rupture of membranes at University of Maiduguri Teaching Hospital, Maiduguri: A cross sectional study. Tropical J Obstet Gynaecol. 2019;36(2):293-8.
Middleton P, Shepherd E, Flenady V, McBain RD, Crowther CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017;1(1):CD005302.
Enjamo M, Deribew A, Semagn S, Mareg M. Determinants of Premature Rupture of Membrane (PROM) Among Pregnant Women in Southern Ethiopia: A Case-Control Study. Int J Womens Health. 2022;14:455-66.
Stancu SMK, Ash LK, Smeding C, Alwan MA. Predictors of Caesarean Delivery in Preterm Premature Rupture of Membranes. Open Access Maced J Med Sci. 2019;7(7):1124-8.
Yang H, Xiao C, Tu J. The effect of gestational diabetes mellitus on pregnancy outcomes in advanced primiparous women: A retrospective study. Medicine. 2024;103(13):e37570.
Bryant A, Sinclair T, Murtha A. Prediction of the latency period by cervical length in preterm premature rupture of membranes. Am J Obstet Gynecol. 2004;191(6):S104.
Gomez R, Romero R, Gomez R, Romero R, Nien JK, Medina L, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Maternal-Fetal Neonatal Med. 2007;20(2):167-73.
Seelbach-Goebel B. Antibiotic therapy for premature rupture of membranes and preterm labor and effect on fetal outcome. Geburtshilfe und Frauenheilkunde. 2013;73(12):1218-27.
Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes Obes Metab. 2006;8:156-63.
Beck C, Gallagher K, Taylor LA, Goldstein JA, Mithal LB, Gernand AD. Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta analysis. Obstet Gynecol. 2021;137(6):1007-22.
Downloads
Published
How to Cite
Issue
Section
